nevirapine has been researched along with Mastitis in 1 studies
Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
Mastitis: INFLAMMATION of the BREAST, or MAMMARY GLAND.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the impact of nevirapine and subclinical mastitis on HIV-1 RNA in maternal plasma and breast milk after intrapartum single-dose nevirapine combined with either 1-week tail of Combivir (zidovudine/lamivudine) or single-dose Truvada (tenofovir/emtricitabine)." | 3.81 | Nevirapine, sodium concentration and HIV-1 RNA in breast milk and plasma among HIV-infected women receiving short-course antiretroviral prophylaxis. ( Bygbjerg, IC; Chiduo, MG; Gerstoft, J; Katzenstein, TL; Lemnge, M; Lüneborg-Nielsen, M; Salado-Rasmussen, K; Theilgaard, ZP, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salado-Rasmussen, K | 1 |
| Theilgaard, ZP | 1 |
| Chiduo, MG | 1 |
| Bygbjerg, IC | 1 |
| Gerstoft, J | 1 |
| Lüneborg-Nielsen, M | 1 |
| Lemnge, M | 1 |
| Katzenstein, TL | 1 |
1 other study available for nevirapine and Mastitis
| Article | Year |
|---|---|
Nevirapine, sodium concentration and HIV-1 RNA in breast milk and plasma among HIV-infected women receiving short-course antiretroviral prophylaxis.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; HIV-1; Humans | 2015 |